Empowered Funds’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAC
6CM
Empowered Funds's RNAC Position: Q3 2026 in Review
Empowered Funds opened a new position in Cartesian Therapeutics (RNAC) in Q3 2026: 25,000 shares worth $180K. The stake represents ﹤0.01% of the portfolio and ranks #2298 among its holdings.
99 funds tracked by Wall St. Rank hold RNAC as of Q3 2026.
- Empowered Funds held 25,000 shares of Cartesian Therapeutics worth $180K as of Q3 2026.
- Cartesian Therapeutics was a new Empowered Funds position in Q3 2026.
- Cartesian Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2298 holding.
- 99 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2026.
Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.